Tech Center 1600 • Art Units: 1651 1657 1692
This examiner grants 70% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18294902 | Compositions, Systems and Methods for Atom Transfer Radical Addition Reaction | Non-Final OA | The Regents of the University of California |
| 18268177 | MEANS AND METHODS FOR MANUFACTURING RACEMIC ALANINE FOR THE MGDA SYNTHESIS | Non-Final OA | BASF SE |
| 18236366 | TRAINED NEURONAL CELL CULTURES FOR DRUG TESTING | Non-Final OA | MICROSOFT TECHNOLOGY LICENSING, LLC |
| 17800320 | GENERATING AORTA-GONAD-MESONEPHROS-LIKE HEMATOPOIETIC CELLS FROM HUMAN PLURIPOTENT STEM CELLS UNDER A DEFINED CONDITION | Non-Final OA | Purdue Research Foundation |
| 16961189 | IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR | Non-Final OA | The General Hospital Corporation |
| 17600931 | DUAL ANTIGEN-RECOGNIZING iPS CELL-DERIVED CHIMERIC ANTIGEN RECEPTOR-T-CELL THERAPY | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 18690537 | POLYSACCHARIDE OR POLYSACCHARIDE MIXTURE PRODUCED BY PAENIBACILLUS POLYMYXA | Non-Final OA | Technische Universität München |
| 17768016 | GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND USE THEREOF IN THE TREATMENT OF CANCER | Non-Final OA | SORBONNE UNIVERSITE |
| 17194761 | METHOD FOR INDUCING ALVEOLAR EPITHELIAL PROGENITOR CELLS | Non-Final OA | KYOTO UNIVERSITY |
| 18775257 | HUMAN IPSC-DERIVED VASCULAR-RELATED AND HEMATOPOETIC CELLS FOR THERAPIES AND TOXICOLOGY/DRUG SCREENINGS | Final Rejection | The USA, as represented by the Secretary, Department of Health and Human Services |
| 18555348 | MAINTENANCE AND/OR CULTURE OF TISSUE SLICES IN VITRO OR EX VIVO | Non-Final OA | SINGAPORE HEALTH SERVICES PTE LTD |
| 18621330 | NOVEL PROTEASES AND USES THEREOF | Non-Final OA | CARBIOS |
| 18577139 | Crystal Structures of ALK and LTK Receptor Tyrosine Kinases and Their Ligands | Non-Final OA | Universiteit Gent |
| 18451280 | CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE | Non-Final OA | GemVax & KAEL CO., LTD. |
| 18482834 | MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE | Non-Final OA | Genomatica, Inc. |
| 18553316 | LIVER ORGANOID MANUFACTURING METHODS, LIVER ORGANOIDS OBTAINED WITH THE SAME, AND USES THEREOF | Non-Final OA | CHU DE NANTES |
| 18550130 | IMMUNE ENHANCERS | Final Rejection | Deutsches Krebsforschungszentrum |
| 17865875 | ANTI-FIBROSIS AGENT AND METHOD OF PRODUCING EXTRACELLULAR VESICLE HAVING ANTI-FIBROSIS ACTION | Non-Final OA | FUJIFILM Wako Pure Chemical Corporation |
| 18546864 | DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY | Non-Final OA | Neutrolis, Inc |
| 17789378 | APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES | Non-Final OA | CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES |
| 18035549 | METHODS FOR SYSTEMATICALLY ASSESSING LOCAL INFLAMMATION AND ACTIVE REPAIR | Non-Final OA | KEYINTEL MEDICAL INC. |
| 17747468 | Inhibitors of DREAM Complex Assembly and/or Function For Use In Repairing DNA Damage | Non-Final OA | Björn Schumacher |
| 17762978 | METHOD FOR MANUFACTURING REPAIRING AGENT FOR BIOLOGICAL TISSUE DAMAGE, AND REPAIRING AGENT FOR BIOLOGICAL TISSUE DAMAGE | Non-Final OA | Hiroshima University |
| 16962686 | Polymer-Encapsulated Viral Vectors for Genetic Therapy | Final Rejection | aratinga.bio TNP |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy